ViroPharma Announces Extension of Hepatitis C Screening Phase of Collaboration with Wyeth
19 juin 2002 08h00 HE
|
ViroPharma Incorporated
EXTON, Pa., June 19, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has extended the screening phase of its HCV drug discovery, development and commercialization...
Notice: ViroPharma Incorporated Teleconference Call
05 juin 2002 07h00 HE
|
ViroPharma Incorporated
EXTON, Pa., June 5, 2002 (PRIMEZONE) -- ViroPharma (Nasdaq:VPHM) will hold a teleconference call today, Wednesday, June 5, 10:30 a.m. (EST) to provide a further update on the Picovir(tm) NDA.
To...
ViroPharma Provides Further Update on Picovir� NDA
04 juin 2002 21h00 HE
|
ViroPharma Incorporated
EXTON, Pa., June 4, 2002 (PRIMEZONE) -- As the Company expected and had previously announced, ViroPharma Incorporated (Nasdaq:VPHM) recently received a "not approvable" letter from the U.S. Food and...
ViroPharma and Aventis Provide Update on Picovir� NDA
09 mai 2002 18h19 HE
|
ViroPharma Incorporated
EXTON, Pa. and BRIDGEWATER, N.J., May 9, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) recently met with officials from the U.S. Food and Drug Administration to discuss ViroPharma's new...
ViroPharma Incorporated Reports First Quarter Financial Results
01 mai 2002 08h00 HE
|
ViroPharma Incorporated
EXTON, Pa., May 1, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today reported financial results for the first quarter ended March 31, 2002.
For the quarter ended March 31, 2002,...
Notice: ViroPharma Incorporated Teleconference Call
19 mars 2002 21h15 HE
|
ViroPharma Incorporated
EXTON, Pa., March 19, 2002 (PRIMEZONE) -- ViroPharma (Nasdaq:VPHM) will hold a teleconference call Wednesday, March 20 10:30 a.m. (EST) to discuss the results of the FDA Advisory Committee meeting...
PICOVIR - pleconaril - Reviewed by FDA Advisory Committee
19 mars 2002 20h31 HE
|
ViroPharma Incorporated
GAITHERSBURG, Md., March 19, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) and Aventis Pharmaceuticals (NYSE:AVE), the U.S. pharmaceutical business of Aventis Pharma AG, announced today...
Picovir -- pleconaril -- to be Reviewed by FDA Antiviral Drugs Advisory Committee on March 19, 2002
06 févr. 2002 04h00 HE
|
ViroPharma Incorporated
EXTON, Pa. and BRIDGEWATER, N.J., Feb. 6, 2002 -- ViroPharma Incorporated (Nasdaq:VPHM) and Aventis Pharmaceuticals, the U.S. pharmaceutical company of Aventis Pharma AG, today announced that the new...